<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-06-09T20:30:07Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/2455-5495.000018">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/2455-5495.000018</identifier>
									<datestamp>2017-05-17</datestamp>
									<setSpec>PTZ.ARDM:VOL3</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										Nephrolithiasis in hypercalcemic and normocalcemic primary Hyperparathyroidism
										</dc:title><dc:creator>Vitorino Modesto dos Santos</dc:creator><dc:description>&lt;p&gt;Primary hyperparathyroidism (PHPT) is a common condition&amp;nbsp; affecting&amp;nbsp; up&amp;nbsp; to&amp;nbsp; 4&amp;nbsp; per 1000 of population,&amp;nbsp; and the&amp;nbsp; majority&amp;nbsp; of&amp;nbsp; cases&amp;nbsp; are&amp;nbsp; due&amp;nbsp; to&amp;nbsp; adenoma&amp;nbsp; or&amp;nbsp; hyperplasia&amp;nbsp; of the&amp;nbsp; gland&amp;nbsp; [1]. This endocrine&amp;nbsp; disorder&amp;nbsp; may&amp;nbsp; either&amp;nbsp; develop without&amp;nbsp; symptoms&amp;nbsp; or&amp;nbsp; be&amp;nbsp; classically&amp;nbsp; manifested&amp;nbsp; by&amp;nbsp; anorexia, nausea,&amp;nbsp; constipation,&amp;nbsp; polydipsia&amp;nbsp; and&amp;nbsp; polyuria&amp;nbsp; in&amp;nbsp; association with&amp;nbsp; hypercalcemia&amp;nbsp; [1].&amp;nbsp; Worthy&amp;nbsp; of&amp;nbsp; note&amp;nbsp; is&amp;nbsp; the&amp;nbsp; form&amp;nbsp; of&amp;nbsp; PHPT described in 2009 and characterized by normocalcemia, which persists&amp;nbsp; with&amp;nbsp; hypercalciuria,&amp;nbsp; nephrolithiasis&amp;nbsp; and&amp;nbsp; bone&amp;nbsp; loss in&amp;nbsp; the&amp;nbsp; majority&amp;nbsp; of&amp;nbsp; the&amp;nbsp; cases 1.&amp;nbsp; Nephrolithiasis&amp;nbsp; can&amp;nbsp; complicate 20%&amp;nbsp; of&amp;nbsp; hypercalcemic&amp;nbsp; and&amp;nbsp; 18.2%&amp;nbsp; of&amp;nbsp; normocalcemic&amp;nbsp; PHPT;&amp;nbsp; moreover, calcium oxalate and calcium phosphate are the main components of the calculi [1]. Thiazide diuretics, lithium salt, immobilization,&amp;nbsp; and&amp;nbsp; inactivity;&amp;nbsp; in&amp;nbsp; addition&amp;nbsp; to&amp;nbsp; hyperoxaluria, hypocitraturia,&amp;nbsp; low&amp;nbsp; urinary&amp;nbsp; pH,&amp;nbsp; high&amp;nbsp; salt&amp;nbsp; ingestion,&amp;nbsp; and&amp;nbsp; low water intake play adverse roles [1]. Cinacalcet hydrochloride is a&amp;nbsp; calciomimetic&amp;nbsp; drug&amp;nbsp; that&amp;nbsp; can&amp;nbsp; activate&amp;nbsp; parathyroid&amp;nbsp; and&amp;nbsp; renal calcium-sensing receptors suppressing synthesis/ secretion of PTH, and&amp;nbsp; reducing&amp;nbsp; calcemia 1. This&amp;nbsp; drug&amp;nbsp; is&amp;nbsp; also&amp;nbsp; used&amp;nbsp; to&amp;nbsp; treat secondary&amp;nbsp; hyperparathyroidism&amp;nbsp; in&amp;nbsp; people&amp;nbsp; with&amp;nbsp; kidney&amp;nbsp; failure [1]. &lt;/p&gt;</dc:description>
										<dc:publisher>Archives of Renal Diseases and Management - Peertechz Publications</dc:publisher>
										<dc:date>2017-05-17</dc:date>
										<dc:type>Letter to Editor</dc:type>
										<dc:identifier>https://doi.org/10.17352/2455-5495.000018</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © Vitorino Modesto dos Santos et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
